Robert F. Kennedy Jr. emphasizes that addressing obesity should primarily focus on lifestyle changes, suggesting this approach is more sustainable than reliance on drugs.
Elon Musk advocates for low-cost GLP inhibitors, stating they could significantly enhance health and longevity for Americans, overshadowing all other methods of combating obesity.
The contrasting views on obesity treatment underscore a larger societal question: Can we effectively change eating habits and the food environment, or must we resort to pharmaceuticals?
Obesity researchers warn that the current food environment promotes unhealthy eating, but new obesity drugs may provide a means to resist these temptations, raising ethical questions.
Collection
[
|
...
]